| Literature DB >> 19430444 |
Abstract
The biotech sector must not only maintain an emphasis on ground-breaking products and focus on retaining key staff but also mobilize to ensure that US health policy continues to reward its innovations.Mesh：
Year: 2009 PMID： 19430444 DOI： 10.1038/nbt0509-424
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908